Zhejiang Sunflower Light Energy - Asset Resilience Ratio

Latest as of March 2026: 9.30%

Zhejiang Sunflower Light Energy (300111) has an Asset Resilience Ratio of 9.30% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥90.07 Million
≈ $13.18 Million USD Cash + Short-term Investments

Total Assets

CN¥968.31 Million
≈ $141.69 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2008–2022)

This chart shows how Zhejiang Sunflower Light Energy's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Zhejiang Sunflower Light Energy to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Sunflower Light Energy's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang Sunflower Light Energy stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥90.07 Million 9.3%
Total Liquid Assets CN¥90.07 Million 9.30%

Asset Resilience Insights

  • Limited Liquidity: Zhejiang Sunflower Light Energy maintains only 9.30% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Sunflower Light Energy Industry Peers by Asset Resilience Ratio

Compare Zhejiang Sunflower Light Energy's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
Drug Manufacturers - Specialty & Generic 2.04%
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
Drug Manufacturers - Specialty & Generic 0.01%
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
Drug Manufacturers - Specialty & Generic 7.85%
Jw Pharmac
KO:001060
Drug Manufacturers - Specialty & Generic 3.65%
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Samjin Pharm
KO:005500
Drug Manufacturers - Specialty & Generic 0.25%

Annual Asset Resilience Ratio for Zhejiang Sunflower Light Energy (2008–2022)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Sunflower Light Energy.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 -0.12% CN¥-723.79K
≈ $-105.91K
CN¥616.25 Million
≈ $90.18 Million
-0.12pp
2021-12-31 0.00% CN¥2.00K
≈ $292.66
CN¥631.63 Million
≈ $92.43 Million
+0.23pp
2020-12-31 -0.23% CN¥-1.28 Million
≈ $-187.15K
CN¥564.44 Million
≈ $82.60 Million
+0.22pp
2019-12-31 -0.45% CN¥-3.11 Million
≈ $-454.84K
CN¥694.03 Million
≈ $101.56 Million
+0.14pp
2018-12-31 -0.58% CN¥-8.50 Million
≈ $-1.24 Million
CN¥1.46 Billion
≈ $213.11 Million
-1.41pp
2012-12-31 0.83% CN¥25.09 Million
≈ $3.67 Million
CN¥3.04 Billion
≈ $444.47 Million
-2.45pp
2011-12-31 3.28% CN¥116.41 Million
≈ $17.03 Million
CN¥3.55 Billion
≈ $519.44 Million
+0.53pp
2010-12-31 2.75% CN¥77.40 Million
≈ $11.33 Million
CN¥2.81 Billion
≈ $411.37 Million
+1.51pp
2008-12-31 1.25% CN¥20.00 Million
≈ $2.93 Million
CN¥1.60 Billion
≈ $234.81 Million
--
pp = percentage points

About Zhejiang Sunflower Light Energy

SHE:300111 China Drug Manufacturers - Specialty & Generic
Market Cap
$544.36 Million
CN¥3.72 Billion CNY
Market Cap Rank
#11657 Global
#3272 in China
Share Price
CN¥2.89
Change (1 day)
+2.85%
52-Week Range
CN¥2.61 - CN¥9.43
All Time High
CN¥9.43
About

Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pne… Read more